Nodal Radiation Doesn't Impact Early Breast Cancer Survival

Share this content:
Nodal Radiation Doesn't Impact Early Breast Cancer Survival
Nodal Radiation Doesn't Impact Early Breast Cancer Survival

THURSDAY, July 23, 2015 (HealthDay News) -- Some women who have surgery for early-stage breast cancer may benefit from additional radiation to nearby lymph nodes, although there is no clear advantage in overall survival, two new clinical trials suggest. The studies were published in the July 23 issue of the New England Journal of Medicine.

Timothy Whelan, B.M., B.Ch., an oncologist at McMaster University and the Hamilton Health Sciences Juravinski Cancer Center in Canada, and colleagues studied 1,832 breast cancer patients who were all given standard therapy for early-stage breast cancer, including breast radiation. Half were randomly assigned to have node radiation, too. Most had one to three affected lymph nodes.

Over the next 10 years, 82 percent of women who received node radiation remained recurrence free -- versus 77 percent of women in the comparison group. About 8 percent of the node-radiation group developed lymphedema, and 1.4 percent had pneumonitis. The most common side effect -- dermatitis -- affected half of the women. After 10 years, 82 percent of study patients were still alive, regardless of whether they'd received node radiation.

The second study, of 4,004 European women, showed a similar pattern: Those who received node radiation had a somewhat lower risk of recurrence over 10 years; 72.1 percent remained free of breast cancer, versus 69.1 percent of the comparison group. However, there was no clear advantage in overall survival.

Full Text - Study 1 (subscription or payment may be required)
Full Text - Study 2 (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »